KK
IRWD icon

KLP Kapitalforvaltning’s Ironwood Pharmaceuticals IRWD Stock Holding History

KLP Kapitalforvaltning’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$733K Hold
174,200
– – ﹤0.01% 1305
2026
Q1 		$611K Hold
174,200
– – ﹤0.01% 1325
2025
Q4 		$587K Hold
174,200
– – ﹤0.01% 1332
2025
Q3 		$228K Hold
174,200
– – ﹤0.01% 1773
2025
Q2 		$125K Sell
174,200
-24,200
-12% -$19K ﹤0.01% 1966
2025
Q1 		$292K Buy
198,400
+174,200
+720% +$415K ﹤0.01% 1575
2024
Q4 		$107K Buy
+24,200
New +$98.2K ﹤0.01% 2058

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

KLP Kapitalforvaltning's IRWD Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 174,200 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

KLP Kapitalforvaltning first reported a position in IRWD in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • KLP Kapitalforvaltning held 174,200 shares of Ironwood Pharmaceuticals worth $733K as of Q2 2026.
  • KLP Kapitalforvaltning left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1305 holding.
  • KLP Kapitalforvaltning first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.